- Home
- MGYR vs IGMS Comparison
MGYR vs IGMS Comparison
Compare MGYR & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- IGMS
- Stock Information
- Founded
- MGYR 1922
- IGMS 1993
- Country
- MGYR United States
- IGMS United States
- Employees
- MGYR N/A
- IGMS N/A
- Industry
- MGYR Savings Institutions
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- MGYR Finance
- IGMS Health Care
- Exchange
- MGYR Nasdaq
- IGMS Nasdaq
- Market Cap
- MGYR 98.9M
- IGMS 82.1M
- IPO Year
- MGYR 2006
- IGMS 2019
- Fundamental
- Price
- MGYR $16.30
- IGMS $1.15
- Analyst Decision
- MGYR
- IGMS Hold
- Analyst Count
- MGYR 0
- IGMS 8
- Target Price
- MGYR N/A
- IGMS $6.00
- AVG Volume (30 Days)
- MGYR 9.7K
- IGMS 303.0K
- Earning Date
- MGYR 07-24-2025
- IGMS 08-13-2025
- Dividend Yield
- MGYR 1.67%
- IGMS N/A
- EPS Growth
- MGYR 19.38
- IGMS N/A
- EPS
- MGYR 1.43
- IGMS N/A
- Revenue
- MGYR $34,067,000.00
- IGMS $2,681,000.00
- Revenue This Year
- MGYR N/A
- IGMS $134.30
- Revenue Next Year
- MGYR N/A
- IGMS $22.37
- P/E Ratio
- MGYR $11.71
- IGMS N/A
- Revenue Growth
- MGYR 12.12
- IGMS 27.36
- 52 Week Low
- MGYR $10.85
- IGMS $0.92
- 52 Week High
- MGYR $17.00
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- MGYR 58.45
- IGMS 49.42
- Support Level
- MGYR $16.05
- IGMS $1.12
- Resistance Level
- MGYR $17.00
- IGMS $1.40
- Average True Range (ATR)
- MGYR 0.27
- IGMS 0.07
- MACD
- MGYR 0.00
- IGMS -0.00
- Stochastic Oscillator
- MGYR 44.03
- IGMS 35.71
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.